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Human immunodeficiency virus type 1 (HIV-1) has tropism for helper T lymphocytes and cells of the monocyte/
macrophage lineages. HIV-1 can also infect other cell types, including B cells. We show here that 10% of fresh circulating B
cells from HIV-1-seronegative donors (i) express the CD4 receptor and CCR5 and CXCR4, two recently described coreceptors
for HIV-1 and (ii) are permissive to HIV-1 with de novo proviral DNA integration following ex vivo infection by either SI
(syncytium-inducing) or NSI (non-syncytium-inducing) isolates. To get further information on the interaction between HIV and
B cells, the susceptibility of several EBV-positive or -negative B cell lines to infection by SI and NSI isolates was checked.
Following infection of an EBV2 CD41 CXCR41 CCR52 B cell line (DG75) by an SI HIV-1 isolate, we obtained a cell line which
chronically produced low-level infectious HIV-1 for 2 years (HIV-DG75). Immunocytochemical data, combined with in situ PCR
data, established that HIV-DG75 cells consist of at least three populations: uninfected cells, infected virus-producing cells,
and infected but nonproducing cells. Moreover, HIV-DG75 cells which express p24 antigen do not go into apoptosis, contrary
to T lymphocytes. We infer from these results that B cells could constitute a reservoir of infectious virus in infected patients.
© 1998 Academic Press
INTRODUCTION
HIV-1 is a retrovirus with preferential tropism for helper T
lymphocytes and cells of the monocyte/macrophage lin-
eage. In addition, HIV-1 can infect Langherans cells and
dendritic follicular cells (Rappersberger et al., 1988;
Tschachler et al., 1988), glial cells (Dewhurst et al., 1987),
some colonic cells (Adachi et al., 1987), and B lymphocytes
(Poznansky et al., 1991; Gras et al., 1993). The first step in
the HIV-1 interaction with target cells involves the CD4
molecule (Dalgleish et al., 1984; Maddon et al., 1986) and
newly characterized coreceptors at the cell surface. These
receptors belong to the chemokine receptor family (Neote
et al., 1993). Importantly, dual modulation of either receptor
together with CD4 renders cells susceptible to HIV-1 sub-
strains with specific tropism: CCR5 and CD4 give rise to
tropism for macrophages and T lymphocytes (NSI, or non-
syncytium-inducing strains), and CXCR4/fusin and CD4 give
rise to specific tropism for T cells (SI, or syncytium-inducing
strains) (Choe et al., 1996; Deng et al., 1996; Doranz et al.,
1996; Dragic et al., 1996; Feng et al., 1996).
B lymphocytes constitute a small but noteworthy pro-
portion of CD4-positive cells (Weber and Weiss, 1988)
and might thus compose a reservoir for HIV. Several
reports have effectively shown that B cells can be in-
fected in vivo (Poznansky et al., 1991), ex vivo (Poulin et
al., 1994), and in vitro (Montagnier et al., 1984; Dahl et al.,
1987, 1990; Salahuddin et al., 1987; Monroe et al., 1988;
Tozzi et al., 1989; DeRossi et al., 1990, 1994).
HIV-1 infection leads to a B lymphocyte dysfunction,
which participates in the progression of the disease
(McCune, 1991). In cooperation with Epstein–Barr virus,
HIV-1 can promote malignant transformation of B cells, at
least in vitro (Laurence and Astrin, 1991). Furthermore,
binding of viral gp 120 to the VH3 domain of surface
immunoglobulins would lead to the activation of B cells
and could explain the B cell depletion observed in symp-
tomatic subjects (Berberian et al., 1993).
We investigated HIV replication both in circulating B
cells purified from peripheral blood mononuclear cells
(PBMC) and in B cell lines. The infecting viruses were
well-characterized SI or NSI HIV-1 isolates. We report: (i)
the existence, among PBMC, of CD4-positive, CCR5-
positive, and CXCR4-positive B lymphocytes which can
be infected ex vivo by HIV-1 and (ii) the establishment
and characterization of a permanently virus-producing
EBV-negative B cell line. This cell line was studied at the
single-cell level in terms of (i) CD4, CCR5, and CXCR4
expression, (ii) HIV-1 status, and (iii) the apoptotic re-
sponse to HIV production. This cell line could provide a
new model for studying B cell infection by HIV.
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RESULTS
Detection of the CD4 receptor on circulating
lymphocytes
Analysis of circulating B cells showed that 10% were
double-positive for CD4 and CD19. This was shown both
by flow cytometry on preparations of peripheral mono-
nuclear cells from HIV-seronegative subjects (Fig. 1A)
and by immunocytochemical analysis of B cells isolated
by purification on magnetic beads coated with an anti-
CD19 antibody (Fig. 1B).
Circulating purified B cells were infected at a low
multiplicity of infection (5 3 1025 TCID50 per cell) from a
stock of SI and NSI HIV-1 isolates. The SI and NSI HIV-1
strains are clinical isolates which have been character-
ized by their cytopathogenic effect following infection of
MT2 cells. The presence of infectious virus was checked
by PCR (gag gene) on extracted DNA over 5 days con-
secutive to infection. Viral DNA was detected whatever
the phenotype (SI or NSI) of the infecting strain (Fig. 2). A
control experiment was done to know the sensitivity
threshold of the PCR conditions used to detect HIV pro-
virus DNA. For this a PCR assay on serial dilutions of 8E5
cells (which contained on average one copy of HIV DNA
per cell) was carried out on material from 1 3 106 cells
down to 1 cell. A detectable signal was obtained for 10
cells (data not shown). A control PCR, carried out on a
part of the HIV supernatant used to infect B cells, did not
show any signal (Fig. 2, lanes 6 and 7).
This experiment confirmed previous studies which
FIG. 1. Detection of CD4 and CD19 markers on B lymphocytes. (A) Flow cytogram of PBMC. Cytograms were gated on PBMC stained with T4-RD1
(y-axis) and B4-FITC (x-axis). Double labeling (CD4-positive and CD19-positive) was observed on 3% of all PBMC. This represents 10% of the entire
B lymphocyte population (27% of PBMC). CD4-positive cells represented 43% of PBMC. This experiment was repeated with four separate pools of cells
from HIV-seronegative donors. (B) Double labeling applied to B lymphocytes purified from PBMC (using the same anti-CD19 antibody but a different
anti-CD4 antibody than that used for flow cytometry) confirmed that B cells expressed the two markers (arrows).
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suggested that circulating B lymphocytes could consti-
tuted a potential reservoir of HIV-1 (Poznansky et al.,
1991; Poulin et al., 1994).
Establishment of an EBV-negative B cell line (DG 75)
continuously producing HIV-1 after in vitro infection
with SI strains
To study interactions between HIV-1 and B lympho-
cytes, several SI and NSI clinical isolates were inocu-
lated onto EBV-positive (B95.8, Namalwa, Raji) and EBV-
negative B cell lines (DG75). Virus replication was mon-
itored by titrating p24 antigen in the supernatant.
A gradual fall (over 20 days) in p24 antigen levels
was observed in the supernatant of the four B cell
lines (DG75, Raji, B95.8, and Namalwa) after infection
by different NSI isolates. When the same cells were
cultured in the presence of several SI clinical HIV
isolates, a similar decrease in p24 antigen levels was
observed with Raji, B95.8, and Namalwa cells. In con-
trast, a time-dependent increase in p24 release was
observed with the EBV-negative B cell line DG75 in-
fected by SI isolates (data not shown). Moreover, in-
fection of DG75 cells by SI HIV-1 isolates was asso-
ciated with syncytia formation during the first 10 days,
as usually observed with T cell lines such as MT2 (Fig.
3). However, in contrast to MT2 cells, which are irre-
versibly destroyed, syncytia disappeared from DG75
cell cultures and this was associated with recovery of
normal growth 3 weeks after infection.
To characterize this ‘‘ HIV carrier state ’’ of B lympho-
cytes, we subcultured one of these chronically HIV-pro-
ducing lines, designated HIV-DG75. HIV-DG75 released
p24 antigen for more than 24 months at a constant level.
Throughout this period, p24 release was associated with
the production of infectious particles, as shown by cul-
turing the supernatant of HIV-DG75 with PBMC each
month (data not shown). Importantly, the HIV-DG75 cell
line still produced SI virus, as confirmed by syncytia
formation after inoculation of MT2 and DG75 cells with
culture supernatant.
DG75 cell infection by SI strains is mediated by the
CD4 receptor
FACS analysis of DG75 cells labeled with surface
markers specific for B lymphocytes (CD19) showed that
this cell line consists exclusively of B cells. Moreover,
30% of DG75 cells bear the CD4 surface marker (Figs. 4A
and 4B). Immunolabeling with another anti-CD4 antibody
confirmed that approximately 30% of DG75 cells bore the
FIG. 2. HIV-1 replication in PBMC and purified circulating B lympho-
cytes was analyzed by amplification of part of the HIV-1 gag gene and
confirmed by Southern blotting with an internal probe for the amplified
fragment. PBMC and B cells were infected by HIV-1 (SI or NSI virus
stocks) at low multiplicity of infection (5 3 1025 TCID50/cell) and
provirus was tested for 5 days later. Viral DNA was detected regardless
of the viral phenotype (SI or NSI). Lane 1, uninfected PBMC; lane 2,
PBMC cultured in the presence of an SI strain; lane 3, PBMC cultured
in the presence of an NSI strain; lane 4, purified B lymphocytes cultured
in the presence of SI strains; lane 5, purified B lymphocytes cultured in
the presence of NSI strains; lane 6, SI virus stock; lane 7, NSI virus
stock; T2, blank PCR (water); T1, PCR on a plasmid containing the
entire HIV-1 sequence.
FIG. 3. Phase-contrast microscopy of DG75 cells infected with SI or NSI HIV-1 strains. (A) Uninfected DG75 cells. (B and C) DG75 cells were
inoculated with an NSI strain. (D and E) DG75 cells were inoculated with an SI strain. Large syncytia were transiently observed 15 days after infection.
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CD4 surface marker (Fig. 4C). Two experiments were
carried out to demonstrate that the CD4 receptor was
effectively required for HIV-1 infection.
First, DG75 cells were cultured in the presence of
anti-CD4 antibody prior to and during infection by an SI
strain. As indicated by measurement of p24 antigen pro-
duction in the culture supernatant, the anti-CD4 antibody
effectively inhibited viral infection (Fig. 5).
Second, CD4-positive and CD4-negative DG75 cells
were separated on antibody-coated magnetic beads and
cultured separately in the presence of SI strains. In
short-term culture, only CD4-positive cells were effi-
ciently infected (data not shown), confirming that the CD4
receptor is required to mediate HIV infection of DG75
cells. Interestingly, CD4-negative DG75 cells expressed
the CD4 receptor de novo after a few months and could
thus be infected by SI strains (data not shown).
We also showed by the two methods described
above that CD4 disappeared from the surface of DG-
HIV cells, suggesting that HIV-1 infection led to CD4
down-regulation.
Analysis of the CCR5 and CXR4 coreceptors
It was recently established that T cell infection by SI
strains requires the CXCR4 cofactor. In contrast, infection
by NSI strains is mediated by the CCR5 cofactor. We
have previously shown that only SI strains can infect
DG75 cells. We therefore investigated the involvement of
CXCR4 expression by these cells. Messenger RNA for
the two coreceptors was tested for by reverse PCR in
different B cell lineages, MT2 cells, PBMC, and circulat-
ing B lymphocytes (Table 1). DG75 cells expressed
CXCR4 transcripts but not CCR5 transcripts, in keeping
with specific infection of DG75 cells by SI strains. The
other B cell lineages expressed CCR5 transcripts and/or
FIG. 4. Analysis of CD4 and CD19 expression on DG75 cells. (A and B) Flow cytograms of DG75 cells. Cytograms were gated on DG75 cells stained
with the two antibodies described in the text. All DG75 cells expressed the CD19 (pan B) marker, and 30% of cells expressed the HIV receptor CD4.
(C) Analysis of CD4 expression using an immunofluorescence procedure (tyramide signal amplification) confirmed that roughly 30% of DG75 cells
expressed the marker.
FIG. 5. HIV-1 infection of DG75 cells is mediated through the CD4 receptor. Cells were infected at a multiplicity of infection of 5 3 1025 TCID50 per
cell. Released p24 antigen was measured as described. (A) DG75 cells were infected with an SI HIV strain in the absence of anti-CD4 Mab. (B) DG75
cells were infected with an SI HIV strain in the presence of anti-CD4 Mab. The four curves represent four independent experiments.
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CXCR4 transcripts at variable levels, but did not express
the CD4 receptor. Finally, fresh circulating B cells ex-
pressed CCR5 and/or CXCR4, in keeping with the fact
that these cells can be infected by both SI and NSI
strains.
Viral persistence in HIV-DG75 cells
HIV-DG75 cells have been continuously producing HIV
for more than 2 years. The continuous growth and virus
production by these cells raises two possibilities: (i)
HIV-DG75 are stably infected and produce HIV without
undergoing apoptosis and (ii) the HIV-DG75 cell line
results from an equilibrium between HIV-producing cells,
which die by apoptosis, and HIV-negative, permissive
(CD4-positive) cells, which generate a permanent pool of
target cells.
We evaluated the number of HIV-infected and p24-
expressing cells among HIV-DG75 cells. Cellular p24
antigen was detected by using a sensitized immunoflu-
orescence assay. Our results indicate that approximately
1 cell per 10,000 expresses cellular p24 antigen (data not
shown). We also performed in situ PCR followed by DNA
hybridization on HIV-DG75 cells (Fig. 6). The results in-
dicated that approximately 1 per 1000 cells harbored the
provirus.
To obtain information on the HIV status of single cells,
we diluted DG-HIV cells and plated them in 96-well
plates at no more than one infected cell per well, thereby
establishing 20 separate subcultures. p24 immunofluo-
rescence and HIV PCR were applied to each subculture.
As shown in Table 2, seven subcultures contained p24
antigen-producing cells, in keeping with the PCR data.
However, 6 of the 20 subcultures harbored HIV DNA but
no detectable cellular or free p24 antigen. The HIV DG75
cell line thus appears to be composed of at least three
subpopulations, two of which are infected by HIV. p24
antigen-negative/HIV DNA-positive cells likely contain
latent or defective viruses. Finally, to correlate cellular
p24 antigen expression with apoptosis in HIV-infected
DG75 cells, we used a fluorescence microscopy device
(Coppey-Moisan et al., 1994) for multiparametric analysis
at the single-cell level, simultaneously recording p24
antigen production and two markers of apoptosis, nu-
clear DNA fragmentation (DAPI labeling) and the exis-
tence of free ends in chromatin DNA (TUNEL reaction).
Figure 7 shows a representative cell positive for p24
antigen, which bears no signs of nuclear apoptosis. A
significant proportion of apoptotic cells did not have
detectable p24 antigen.
This suggests that HIV production can occur in the
TABLE 1






CXCR4 CCR5 SI strains NSI strains
DG75 11 2 1 1 2
DG75-HIV 11 2 2 ND ND
B95.8 1/2 11 2 2 2
Raji 1 2 2 2 2
Namalwa 1 1/2 2 2 2
MT2 11 1/2 1 1 2
PBMC 11 11 1 1 1
B lymphocytes 11 11 1 1 1
a Cells were tested for CCR5 and CXCR4 mRNA expression (RT-PCR) and CD4 antigen as described in the text.
b The expression level of CXCR4 and CCR5 RT-PCR products (Southern blotting) fell into four arbitrary classes (PBMC expression was the reference
for high expression), as follows: 11, high expression; 1, medium expression; 1/2, low or very low expression; 2, no expression.
c CD4 antigen expression was determined by FACS analysis and immunofluorescence as described in the text.
d ND, not done; 2, no infection; 1, infection.
FIG. 6. Detection of proviral HIV DNA by in situ PCR in infected cells.
After amplification and hybridization, no signal was observed in unin-
fected MT2 or DG75 cells. Syncytia in infected MT2 cells were strongly
stained in this procedure. Likewise, approximately 1/5000 HIV-DG75
cells stained positively with this method (white arrow).
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absence of detectable apoptosis in HIV DG75 cells.
However, these experiments did not exclude the pos-
sibility that persistent HIV infection of DG75 cells may
result from continuous cell-to-cell infection. If so, one
would expect this process to be mediated by infection
of an uninfected pool of CD4-positive cells. To inves-
tigate this possibility, we monitored the production of
soluble p24 antigen during HIV DG75 cell culture in
the presence of an anti-CD4 antibody. The results (Fig.
8) indicated that the anti-CD4 antibody efficiently re-
duced p24 antigen production and therefore probably
blocked the reinfection process. Furthermore, the in-
hibition kinetics suggests that viral spread is very slow
in the HIV-DG75 cell line.
DISCUSSION
We found that about 10% of B lymphocytes derived
from PBMC were CD4-positive. The presence of CD4
antigen was shown by flow cytometry and confirmed
by immunocytochemical detection of CD4 and CD19.
These CD4-positive B lymphocytes were readily in-
fected by SI and NSI HIV strains. Infection probably
required the CD4 receptor and the CCR5 and/or fusin/
CXCR4 coreceptors. Indeed, we found that both core-
ceptor genes were actively transcribed in a pool of B
lymphocytes purified from PBMC.
To study B cell infection by HIV-l, we screened B cell
lines susceptible to infection by SI or NSI strains.
Among several EBV-negative or EBV-positive labora-
tory cell lines, we found that DG75, an EBV-negative
Burkitt-derived cell line, was readily and specifically
infected by SI strains of HIV. Infection was mediated by
the CD4 receptor and was associated with CXCR4
coreceptor expression.
Interestingly, the infection process was characterized
by transient syncytia formation, during which the cells
produced HIV before returning to a growth pattern com-
parable to that of normal cells. These infected cells have
continuously grown and produced HIV for more than 2
years. One of these continuously virus-producing cell
lines, HIV-DG75, was used to investigate the mecha-
nisms of viral persistency. We found that HIV DG75 is a
mixed cell line composed of three different subpopula-
tions: (i) uninfected cells, (ii) infected, nonproducing
cells, and (iii) p24 antigen-producing cells.
At least two mechanisms may explain the persistent
infection of HIV-DG75 cells. First, infected cells may be
able to produce HIV without undergoing apoptosis. Sev-
eral studies have shown that apoptosis associated with
HIV production is due to direct binding of newly synthe-
sized GP120 to the CD4 receptor (Terai et al., 1991;
Banda et al., 1992). Consequently, such a mechanism
would be possible if HIV-infected DG75 cells do not
express the CD4 surface marker (Stevenson et al., 1988).
The CD4 molecule could not be detected on HIV DG75
cells by immunocytochemistry or FACS analysis (data
not shown). However, persistent HIV infection of DG75
required CD4 expression, as it was blocked by the ad-
dition of an anti-CD4 antibody. Whether CD4 is ex-
pressed at a very low level or is continuously repressed
following HIV infection remains to be determined.
These observations strongly suggest that the CD4 mol-
ecule is efficiently expressed by some uninfected cells,
thus generating a pool of potential targets. Moreover, CD4
expression is likely to be tightly regulated in these cells.
Indeed, constitutive expression of CD4 on every cell would
quickly lead to the elimination of all DG75 cells on exposure
to the virus. Several attempts were made to separate and
independently clone CD4-positive and CD4-negative DG75
cells. CD4-negative DG75 cells were not permissive for
infection by SI strains in the days following the cloning
procedure, suggesting that they did not express CD4, even
at a very low level. However, CD4 became detectable by
FACS analysis and immunochemistry in a stable proportion
(;30%) of cells during long-term culture—more than 3
months (data not shown).
Taken together, these data point to the following mech-
anism of HIV infection in DG75 cells. SI HIV-1 strains can
enter CD4-positive/CXR4-positive DG75 cells. The initial
fraction of CD4-positive cells in the population is large
enough (30%) to give rise, by contiguity, to syncytia forma-
tion during the first week of infection. Later, owing to the
gradual elimination of CD4-positive cells, most surviving
cells are CD4-negative cells, newly generated CD4-positive
cells, or nonproductive, uninfected cells. It remains to be
determined if HIV-producing cells are susceptible to HIV-
mediated cell death.
More surprising was the remarkable stability of a very
small fraction (1/5000) of HIV-infected cells during long-
term culture. The following mechanism might explain this
persistent virus production: (i) HIV-releasing cells do not
disappear through HIV-induced apoptosis, owing to a
lack of the CD4 receptor, (ii) subsequent upregulation of
the CD4 receptor on CD4-negative B lymphocytes,
through an unknown process, would allow secondary
infection to take place by infectious particles released
into the supernatant. The two processes would have to
be intimately coupled to ensure stable virus production.
TABLE 2
Analysis of 20 Separate Subcultures by HIV-1 gag DNA
Amplification and p24 Immunofluorescence
Number of subculture (n 5 20)
7 6 7
gag DNA amplificationa 1 1 2
p24 immunofluorescenceb 1 2 2
a 1 signifies a positive signal after DNA amplification and hybridiza-
tion with a specific labeled-probe.
b 1 indicates the presence of stained cells using p24 detection by
tyramide signal amplification as described under Materials and
Methods.
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Taken together, these results show that B cells can
potentially be infected by HIV-1 in vivo and could com-
pose a viral reservoir in infected subjects.
MATERIALS AND METHODS
Cells
B95.8, Namalwa, and Raji are EBV-positive lympho-
blastoid B-cell lines (American Type Culture Collec-
tion, Rockville, MD). DG75 is an EBV-negative B cell
line (Ben-Bassat et al., 1977). MT2 cells, kindly pro-
vided by C. Boucher, are T cells harboring the HTLV-1
genome. 8E5 cells are T cells which contain one HIV-1
provirus per cell (Folks et al., 1986). The cell lines were
grown in RPMI 1640 medium (Gibco BRL) with 10%
fetal bovine serum and antibiotics. Cells were split
twice a week and maintained in 5% CO2 at 37°. PBMC
were isolated from heparinized venous blood by Ficoll/
FIG. 7. Lack of apoptosis in HIV-DG75 p24-expressing cells. (A) Cell expressing p24 antigen, stained using the TSA procedure (a) showed a structured
chromatin without condensation or fragmentation (b) and gave no signal in the TUNEL labeling procedure (c). Some uninfected cells (d) showed chromatin
fragmentation (e) and incorporation of fluorescein-labeled nucleotide in the TUNEL reaction (original magnification, 10003). (B) HIV-DG75 cells were doubly
labeled with the DNA-specific dye DAPI and by the TUNEL method. Both procedures allow apoptotic and nonapoptotic cells to be visualized.
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Hypaque density-gradient centrifugation. When appro-
priate, PBMC were cultured in RPMI medium with 10%
fetal bovine serum, antibiotics, and interleukin 2 (20
U/ml). PBMC were stimulated prior to infection with
HIV-1 by adding phytohemagglutinin (PHA, 450 mg/ml)
to the medium. CD4-positive and CD19-positive cells
were purified on anti-CD4-coated or anti-CD19-coated
beads as recommended by the manufacturer (Dyna-
bead kits, Dynal A.S, Oslo, Norway).
HIV strains and infection
To determine wether SI and NSI strains were able to
infect B cell lines, 15 NSI and 15 SI clinical isolates were
used for this study. A total of 5 3 106 B cells in 0.5 ml of
medium were incubated with 0.5 ml of cell-free HIV
supernatant for 1 h at 37°. The cells were pelleted at
low-speed centrifugation and resuspended in culture
medium. Supernatants from these cell cultures were
assayed weekly for p24 antigen production by using an
antigen-capture ELISA (NEN DuPont).
Virus titration
All further experiments were conducted using the
same concentrated, purified virus stocks (one SI and one
NSI). Before titration, viruses in culture supernatant were
partially purified by sedimentation at 100,000 rpm for 10
min at 4° and resuspended in 1 ml of complete medium
for each 100 ml medium, and concentrated virus was
stored at 280°. The titer was determined on PHA-acti-
vated PBMC in vitro to obtain relative 50% cell culture-
infective doses (TCID50) as previously described
(Kaneshima et al., 1991).
In blocking tests, an anti-CD4 monoclonal antibody
(MoAb) provided by Dr. J. P. Vendrell was used at a
concentration of 2 mg/ml. HIV-1 was inoculated at a
multiplicity of infection of 5 3 1025 ID50 per cell.
Immunofluorescence and flow cytometry
Cells were fixed with methanol at 20° for 30 min for
p24 detection or with 4% paraformaldehyde at 20° for
30 min for CD4 detection and then washed with phos-
phate-buffered saline (PBS). Fixed cells were incu-
bated at room temperature for 30 min with a primary
MoAb to p24 antigen (1:400 dilution in PBS–1% Tween
20 of anti-p24 antibody from Biosoft) or to CD4 (1:10
dilution, in the same buffer, of antibody MT310 from
Dako). After three washes in TNT (100 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 0.5% Tween 20), cells were
incubated for 15 min at 37° with goat serum (1:10 in
TNB, 100 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5%
DuPont blocking reagent) and with a second antibody
(peroxidase-labeled anti-goat antibody from Dako) di-
luted 1:100 in TNB. After washing in TNT, cells were
labeled with tyramide–FITC or tyramide–tetramethyl-
rhodamine diluted 1:20 (direct TSA detection kit, NEN
DuPont) for 15 min. After a further wash in TNT, cells
were counterstained with Evans blue.
The CD4 and CD 19 markers were also determined by
flow cytometry using antibodies B4-FITC (CD19) and T4-
RD1 (CD4) from Coulter on an Epics profile analyser
(Coulter).
Nucleic acid extraction and PCR assays
Genomic DNA, RNA, and cDNA were prepared as
previously described (Maniatis et al., 1982). DNA and
RNA concentrations were standardized by measuring
UV absorbance at 260 nm. Reactions were run in a
50-ml volume containing 100 to 500 ng of DNA or
cDNA, 250 pmol of each primer, 5 ml of each de-
oxynucleoside triphosphate (2 mM), 5 ml of 103 buffer
(350 mM KCl, 100 mM Tris-HCl, pH 8, 15 mM MgCl2),
and 0.5 U of Taq polymerase (ATGC). PCR consisted of
94° for 10 min and 40 cycles of denaturation at 94° for
FIG. 8. Culture of virus-producing cell subpopulations (clones 1 and 2) in the presence of a neutralizing anti-CD4 antibody. p24 antigen was
measured in the culture medium as described in the text. p24 antigen levels fell after 3 weeks to a persistent, minimal threshold level. Controls without
antibodies showed the persistence of antigen production.
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30 s, annealing at 55° for 30 s, and polymerization for
45 s at 72°, with a final round of elongation for 5 min
at 72°. Upstream and downstream oligonucleotide
primers were as follows: gag, 59-GGAGCCACCCCA-
CAAGAT and 59CAAGGTTTCTGTCATCCA; CCR5, 59-
CTCGGATCCGGTTGGAAC and 59-CTCGTCGACATGT-
GCACA; CXCR4, 59-GGCTAAAGCTTGGCCTGA and 59-
CGTCCTCGAGCATCTGTGTTAGC TGGAG.
DNA was analyzed by agarose gel electrophoresis
with transfer to PVDF membranes (NEN DuPont de
Nemours) using the Southern method (Southern, 1975).
PCR products were detected by hybridization with the
specific PCR product labeled with Biotin-N6–dATP (NEN
DuPont de Nemours) using the PCR procedure.
Codetection of apoptosis and p24 antigen
After immunodetection of p24 antigen as described
above, apoptosis was detected in a TUNEL reaction ac-
cording to the manufacturer’s recommendations (in situ cell
death detection kit, Boehringer Mannheim) and by DNA
staining with DAPI (1 mg/ml). Cell labeling and digital fluo-
rescence imaging microscopy were carried out as de-
scribed elsewhere (Coppey-Moisan et al., 1994).
PCR amplification and detection of amplified HIV DNA
in situ
Cells were fixed in 4% paraformaldehyde and cytocen-
trifuged. After incubation with 0.2 N HCl for 15 min the
slides were washed in 10 mM Tris (pH 7.5) and cells
were digested with 1 mg/ml proteinase K in 10 mM
Tris-HCl, pH 7.5, for 30 min at 37°. After digestion, the
slides were washed in 10 mM Tris–HCl, pH 7.5/0.2%
glycine for 5 min and in 10 mM Tris–HCl, pH 8.5. Before
amplification, the cells were incubated in a saturation
solution (350 mM KCl, 100 mM Tris–HCl, pH 8.5, 2.5 mM
MgCl2, 0.5% Tween 20, 0.2 mM each dNTP, and 2%
blocking reagent from Boehringer Mannheim) for 30 min
at 37° and then washed twice.
For amplification in situ, 50 ml of PCR mixture (5 ml of
103 PCR buffer described above, 2 ml of each de-
oxynucleoside (10 mM), 2 ml of each gag primer (50
pmol/ml), 5 ml of 5% Tween 20, 32 ml of water, and 10 U
of Taq polymerase) was added to each cell preparation
and cells were then overlaid with a coverslip (Perkin–
Elmer). After a denaturation step at 94° for 7 min, 30
denaturation cycles at 94° for 1 min, and annealing at
52° for 2 min, followed by a final polymerization step at
72° for 7 min, the slides were removed from the thermo-
cycler, washed twice for 5 min in TBS buffer (100 mM
Tris–HCl, pH 7.5, 150 mM NaCl), and dehydrated in 100%
ethanol. Before in situ hybridization, cells were incubated
in prehybridization solution (0.2% blocking reagent, 13
Denhardt, 10% dextran sulfate, salmon sperm (250 mg/
ml), 103 formamide, and 0.33 SSC) for 30 min at 37°.
Cell preparations were then hybridized overnight to a
biotin-labeled probe. The probe was labeled in a PCR
procedure using sk38-sk39 primers (GENSET) and Dig-
11–dUTP (Boehringer Mannheim) following the manufac-
turer’s instructions.
After hybridization and two washing steps in 23 SSC
and 0.13 SSC, endogenous peroxidase activity was
blocked by incubating the slides in PBS/1% H2O2 for 15
min at room temperature. Nonspecific antibody binding
was blocked with goat serum in TNB, according to the
manufacturer’s protocol (NEN DuPont). Cells were then
incubated with biotinylated secondary antibody (goat an-
ti-digoxigenin IgG, Boehringer) for 45 min at 37°, washed
three times in TNT buffer, and incubated with biotin
tyramide solution for 15 and 30 min with Streptavidin–
peroxidase according to the manufacturer’s instructions
(NEN DuPont). After being washed three times in TNT,
cells were placed in TBS with diaminobenzidine (DAB,
Sigma) at 140 ml/ml and 0.1% H2O2 and washed in TBS/
0.1% Triton 3100.
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